Compound ID | 874
Class: Quinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Greater potency than WQ175 in vitro studies against tested species ranging from Staphylocci (MRSA and MSSA), Enterococci, Klebsiella, and Pseudomona. |
| Institute where first reported: | Wakunaga Pharma. Japan |
| Year first mentioned: | 1991 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |